{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T19:46:34Z","timestamp":1648755994406},"reference-count":0,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[1973,3,1]],"date-time":"1973-03-01T00:00:00Z","timestamp":99792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Infect Immun"],"published-print":{"date-parts":[[1973,3]]},"abstract":"<jats:p>\n            We examined the effect of experimental meningeal infection with a neuraminidase-producing strain of\n            <jats:italic>Diplococcus pneumoniae<\/jats:italic>\n            on the\n            <jats:italic>N<\/jats:italic>\n            -acetylneuraminic acid (NANA) content of canine cerebral cortical gray matter. The Warren thiobarbituric acid assay for NANA was used. There was no significant difference between the free and bound NANA levels of the tissue from control animals and from those with meningitis. This finding suggests that the neurological impairment so frequent in clinical pneumococcal meningitis is not a result of the activity of this bacterial enzyme upon cortical glycolipids.\n          <\/jats:p>","DOI":"10.1128\/iai.7.3.370-372.1973","type":"journal-article","created":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T14:17:47Z","timestamp":1578061067000},"page":"370-372","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":1,"title":["Effect of Pneumococcal Neuraminidase on Canine Cerebral Cortex in Experimental Meningitis"],"prefix":"10.1128","volume":"7","author":[{"given":"M. M.","family":"Carruthers","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Chicago Medical School, Mount Sinai Hospital, Chicago, Illinois 60608"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Kanokvechayant","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Chicago Medical School, Mount Sinai Hospital, Chicago, Illinois 60608"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","container-title":["Infection and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/iai.7.3.370-372.1973","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/iai.7.3.370-372.1973","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T13:16:34Z","timestamp":1646486194000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/iai.7.3.370-372.1973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1973,3]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1973,3]]}},"alternative-id":["10.1128\/iai.7.3.370-372.1973"],"URL":"https:\/\/doi.org\/10.1128\/iai.7.3.370-372.1973","relation":{},"ISSN":["0019-9567","1098-5522"],"issn-type":[{"value":"0019-9567","type":"print"},{"value":"1098-5522","type":"electronic"}],"subject":[],"published":{"date-parts":[[1973,3]]},"assertion":[{"value":"1973-03-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}